Mumbai: Dabur Pharma today posted a 22.70% rise in net profit at Rs8.54 crore for the quarter ended 30 September as compared to Rs6.96 crore for the corresponding period last year.
The total income of the company declined to Rs66.64 crore for the reviewed quarter as against Rs94.29 crore for the same period a year ago, down 29.32%, the company informed the Bombay Stock Exchange.
Shares of the company were trading at Rs64.95, up 2.53%, at the BSE.